Total Payments
$1.1M
2024 Payments
$248,678
Companies
52
Transactions
2,522
Medicare Patients
23,993
Medicare Billing
$4.6M
Payment Breakdown by Category
Other$750,675 (68.4%)
Consulting$146,125 (13.3%)
Travel$127,166 (11.6%)
Research$36,872 (3.4%)
Food & Beverage$36,645 (3.3%)
Education$303.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $748,925 | 427 | 68.2% |
| Consulting Fee | $146,125 | 51 | 13.3% |
| Travel and Lodging | $127,166 | 303 | 11.6% |
| Unspecified | $36,872 | 3 | 3.4% |
| Food and Beverage | $36,645 | 1,724 | 3.3% |
| Honoraria | $1,750 | 1 | 0.2% |
| Education | $303.96 | 13 | 0.0% |
Payments by Type
General
$1.1M
2,519 transactions
Research
$36,872
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $497,209 | 789 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $161,286 | 185 | $0 (2024) |
| Lilly USA, LLC | $119,103 | 209 | $0 (2024) |
| Amgen Inc. | $74,275 | 272 | $0 (2024) |
| GENZYME CORPORATION | $52,747 | 93 | $0 (2024) |
| AstraZeneca UK Limited | $40,750 | 20 | $0 (2024) |
| Eli Lilly and Company | $40,647 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $40,025 | 164 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $39,112 | 111 | $0 (2024) |
| UCB, Inc. | $13,456 | 99 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248,678 | 381 | ABBVIE INC. ($119,718) |
| 2023 | $171,744 | 348 | AbbVie Inc. ($67,963) |
| 2022 | $219,371 | 413 | ABBVIE INC. ($116,172) |
| 2021 | $69,223 | 277 | AbbVie Inc. ($43,978) |
| 2020 | $87,991 | 253 | AbbVie Inc. ($43,345) |
| 2019 | $165,945 | 333 | AbbVie, Inc. ($63,253) |
| 2018 | $83,645 | 325 | GENZYME CORPORATION ($32,181) |
| 2017 | $51,188 | 192 | Amgen Inc. ($33,126) |
All Payment Transactions
2,522 individual payment records from CMS Open Payments — Page 1 of 101
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Travel and Lodging | Cash or cash equivalent | $77.05 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,430.00 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Immunology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Immunology | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $401.95 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $237.86 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $208.91 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $39.07 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | Eli Lilly and Company | $36,872 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 60 | 6,584 | 166,354 | $4.2M | $1.8M |
| 2022 | 56 | 5,546 | 120,112 | $3.2M | $1.3M |
| 2021 | 57 | 6,026 | 28,993 | $2.2M | $875,440 |
| 2020 | 66 | 5,837 | 22,446 | $1.6M | $672,806 |
Total Patients
23,993
Total Services
337,905
Medicare Billing
$4.6M
Procedure Codes
239
All Medicare Procedures & Services
239 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0491 | Injection, anifrolumab-fnia, 1 mg | Office | 2023 | 29 | 44,742 | $1.4M | $562,766 | 39.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 13 | 57,827 | $462,584 | $270,534 | 58.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 613 | 2,150 | $451,500 | $193,099 | 42.8% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 13 | 2,410 | $316,800 | $152,647 | 48.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 81 | 7,923 | $229,680 | $145,359 | 63.3% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 14 | 37,200 | $511,500 | $145,331 | 28.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 79 | 510 | $125,460 | $50,177 | 40.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 161 | 667 | $81,374 | $40,157 | 49.3% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 160 | 1,536 | $75,264 | $26,744 | 35.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 95 | 341 | $46,376 | $18,993 | 41.0% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 81 | 213 | $38,448 | $17,313 | 45.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 396 | 540 | $39,960 | $15,364 | 38.4% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2023 | 15 | 984 | $59,040 | $13,125 | 22.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 468 | 1,024 | $29,696 | $10,408 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $25,040 | $9,214 | 36.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 459 | 1,032 | $21,672 | $7,715 | 35.6% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2023 | 119 | 123 | $18,819 | $7,410 | 39.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 496 | 1,246 | $7,476 | $7,186 | 96.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 91 | 91 | $9,100 | $6,899 | 75.8% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 11 | 51 | $16,014 | $5,100 | 31.8% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 433 | 943 | $13,202 | $4,703 | 35.6% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 432 | 953 | $9,530 | $3,911 | 41.0% |
| 86160 | Measurement of complement (immune system proteins), antigen, | Office | 2023 | 167 | 322 | $10,626 | $3,743 | 35.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 98 | 98 | $9,016 | $3,548 | 39.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 109 | 109 | $4,360 | $3,217 | 73.8% |
About Dr. Pendleton Wickersham, M.D
Dr. Pendleton Wickersham, M.D is a Rheumatology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053380048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pendleton Wickersham, M.D has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $248,678 received in 2024. These payments were reported across 2,522 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($748,925).
As a Medicare-enrolled provider, Wickersham has provided services to 23,993 Medicare beneficiaries, totaling 337,905 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 239 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location San Antonio, TX
- Active Since 03/14/2006
- Last Updated 02/01/2015
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1053380048
Products in Payments
- RINVOQ (Biological) $298,330
- SAPHNELO (Biological) $184,551
- TALTZ (Drug) $106,555
- SKYRIZI (Biological) $38,945
- COSENTYX (Biological) $38,639
- SIMPONI ARIA (Biological) $34,959
- Rinvoq (Biological) $33,172
- Enbrel (Biological) $29,943
- Humira (Biological) $27,528
- HUMIRA (Biological) $23,245
- KEVZARA (Drug) $22,666
- RINVOQ (Drug) $22,204
- NO PRODUCT DISCUSSED (Drug) $19,770
- KEVZARA (Biological) $11,618
- Bimzelx (Biological) $7,001
- Cimzia (Drug) $5,869
- XELJANZ (Drug) $5,065
- TREMFYA (Drug) $4,710
- LUPKYNIS (Drug) $2,765
- BENLYSTA (Biological) $2,688
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in San Antonio
Dr. Alex De Jesus, Md, MD
Rheumatology — Payments: $273,995
Rheumatology $273,995
Kevin Kempf, Md, MD
Rheumatology — Payments: $154,966
Rheumatology $154,966
Dr. Thomas Rennie, M.d, M.D
Rheumatology — Payments: $135,935
Rheumatology $135,935
Dr. Fernando Silva, M.d, M.D
Rheumatology — Payments: $53,617
Rheumatology $53,617
Everett Allen, Md, MD
Rheumatology — Payments: $28,103
Rheumatology $28,103
Dr. Emily Pineda, M.d, M.D
Rheumatology — Payments: $20,974
Rheumatology $20,974